CDC Website CDC Website

To Join the NPIN community or

COVID-19: General Information | Testing | Vaccines |

Contact Organizations directly about changes to services or hours

Home » Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)

Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)

The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities; (2) drug abuse treatment and adherence interventions; (3) drug abuse treatment and adherence interventions that utilize technologies to boost effects and increase implementability and sustainability; (4) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (5) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (6) interventions to treat substance misuse and chronic pain. Research of interest includes but is not limited to Stage II and Stage III efficacy research.

Funding Organization
US Department of Health and Human Services National Institutes of Health
Funding Category
HIV/AIDS
Other Health-Related
Support Types
Discretionary Grants
Locations
International, National
Eligible Organizations
City Agencies
Colleges/Universities
County Agencies
Educational Organizations/Institutions
International Agencies
IRS 501 (c)(3) Organizations
Nonprofit Organizations
State Agencies
Tribal Organizations
Application Due Date
3/21/25
Application Contact
Ericka
Wells
National Institute on Drug Abuse (NIDA)
301.827.5909
wellse2@nida.nih.gov
Technical Contact
Will
Aklin
Scientific/Research Contact NIDA
aklinwm@mail.nih.gov
Subjects
HIV/AIDS Prevention
Medical Treatments and Therapies
Audiences
Persons with HIV/AIDS
Substance Abusers

Fund Number: 

364338

Fund ID: 

PAR-22-182

Last modified: 

5/11/22